Global Blood Cancer Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 83 pages | ID: G4F132E3109EN
LP Information

Abstracts

According to this study, the global Blood Cancer Therapeutics market size will reach US$ million by 2031.

Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Blood Cancer Therapeutics Industry Forecast” looks at past sales and reviews total world Blood Cancer Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Cancer Therapeutics sales for 2025 through 2031. With Blood Cancer Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Cancer Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Blood Cancer Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Cancer Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Cancer Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Cancer Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Cancer Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Cancer Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chronic Myeloid Leukemia (CML)
• Acute Lymphocytic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
• Acute Myeloid Leukemia (AML)

Segmentation by Application:

• Cancer Research Centers
• Cancer Hospital
• Surgical Centers
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• AstraZeneca
• Bristol-Myers Squibb
• GlaxoSmithKline
• Roche
• Novartis
• Boehringer Ingelheim
• Pfizer
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Blood Cancer Therapeutics Market Size (2020-2031)
  2.1.2 Blood Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Blood Cancer Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Blood Cancer Therapeutics Segment by Type
  2.2.1 Chronic Myeloid Leukemia (CML)
  2.2.2 Acute Lymphocytic Leukemia (ALL)
  2.2.3 Chronic Lymphocytic Leukemia (CLL)
  2.2.4 Acute Myeloid Leukemia (AML)
2.3 Blood Cancer Therapeutics Market Size by Type
  2.3.1 Blood Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Blood Cancer Therapeutics Segment by Application
  2.4.1 Cancer Research Centers
  2.4.2 Cancer Hospital
  2.4.3 Surgical Centers
  2.4.4 Clinics
2.5 Blood Cancer Therapeutics Market Size by Application
  2.5.1 Blood Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)

3 BLOOD CANCER THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Blood Cancer Therapeutics Market Size Market Share by Player
  3.1.1 Global Blood Cancer Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Blood Cancer Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Blood Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BLOOD CANCER THERAPEUTICS BY REGION

4.1 Blood Cancer Therapeutics Market Size by Region (2020-2025)
4.2 Global Blood Cancer Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Cancer Therapeutics Market Size Growth (2020-2025)
4.4 APAC Blood Cancer Therapeutics Market Size Growth (2020-2025)
4.5 Europe Blood Cancer Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Blood Cancer Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Blood Cancer Therapeutics Market Size by Country (2020-2025)
5.2 Americas Blood Cancer Therapeutics Market Size by Type (2020-2025)
5.3 Americas Blood Cancer Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Blood Cancer Therapeutics Market Size by Region (2020-2025)
6.2 APAC Blood Cancer Therapeutics Market Size by Type (2020-2025)
6.3 APAC Blood Cancer Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Blood Cancer Therapeutics Market Size by Country (2020-2025)
7.2 Europe Blood Cancer Therapeutics Market Size by Type (2020-2025)
7.3 Europe Blood Cancer Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Blood Cancer Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Blood Cancer Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Blood Cancer Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BLOOD CANCER THERAPEUTICS MARKET FORECAST

10.1 Global Blood Cancer Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Blood Cancer Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Blood Cancer Therapeutics Forecast
  10.1.3 APAC Blood Cancer Therapeutics Forecast
  10.1.4 Europe Blood Cancer Therapeutics Forecast
  10.1.5 Middle East & Africa Blood Cancer Therapeutics Forecast
10.2 Americas Blood Cancer Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Blood Cancer Therapeutics Forecast
  10.2.2 Canada Market Blood Cancer Therapeutics Forecast
  10.2.3 Mexico Market Blood Cancer Therapeutics Forecast
  10.2.4 Brazil Market Blood Cancer Therapeutics Forecast
10.3 APAC Blood Cancer Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Blood Cancer Therapeutics Market Forecast
  10.3.2 Japan Market Blood Cancer Therapeutics Forecast
  10.3.3 Korea Market Blood Cancer Therapeutics Forecast
  10.3.4 Southeast Asia Market Blood Cancer Therapeutics Forecast
  10.3.5 India Market Blood Cancer Therapeutics Forecast
  10.3.6 Australia Market Blood Cancer Therapeutics Forecast
10.4 Europe Blood Cancer Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Blood Cancer Therapeutics Forecast
  10.4.2 France Market Blood Cancer Therapeutics Forecast
  10.4.3 UK Market Blood Cancer Therapeutics Forecast
  10.4.4 Italy Market Blood Cancer Therapeutics Forecast
  10.4.5 Russia Market Blood Cancer Therapeutics Forecast
10.5 Middle East & Africa Blood Cancer Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Blood Cancer Therapeutics Forecast
  10.5.2 South Africa Market Blood Cancer Therapeutics Forecast
  10.5.3 Israel Market Blood Cancer Therapeutics Forecast
  10.5.4 Turkey Market Blood Cancer Therapeutics Forecast
10.6 Global Blood Cancer Therapeutics Forecast by Type (2026-2031)
10.7 Global Blood Cancer Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Blood Cancer Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Blood Cancer Therapeutics Product Offered
  11.1.3 AbbVie Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca Blood Cancer Therapeutics Product Offered
  11.2.3 AstraZeneca Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Blood Cancer Therapeutics Product Offered
  11.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Company Information
  11.4.2 GlaxoSmithKline Blood Cancer Therapeutics Product Offered
  11.4.3 GlaxoSmithKline Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline Main Business Overview
  11.4.5 GlaxoSmithKline Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche Blood Cancer Therapeutics Product Offered
  11.5.3 Roche Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Blood Cancer Therapeutics Product Offered
  11.6.3 Novartis Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Boehringer Ingelheim
  11.7.1 Boehringer Ingelheim Company Information
  11.7.2 Boehringer Ingelheim Blood Cancer Therapeutics Product Offered
  11.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Boehringer Ingelheim Main Business Overview
  11.7.5 Boehringer Ingelheim Latest Developments
11.8 Pfizer
  11.8.1 Pfizer Company Information
  11.8.2 Pfizer Blood Cancer Therapeutics Product Offered
  11.8.3 Pfizer Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Pfizer Main Business Overview
  11.8.5 Pfizer Latest Developments
11.9 Sanofi
  11.9.1 Sanofi Company Information
  11.9.2 Sanofi Blood Cancer Therapeutics Product Offered
  11.9.3 Sanofi Blood Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sanofi Main Business Overview
  11.9.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Blood Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Blood Cancer Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chronic Myeloid Leukemia (CML)
Table 4. Major Players of Acute Lymphocytic Leukemia (ALL)
Table 5. Major Players of Chronic Lymphocytic Leukemia (CLL)
Table 6. Major Players of Acute Myeloid Leukemia (AML)
Table 7. Blood Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Blood Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Blood Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Blood Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Blood Cancer Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Blood Cancer Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Blood Cancer Therapeutics Key Players Head office and Products Offered
Table 16. Blood Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Blood Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Blood Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Blood Cancer Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Blood Cancer Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Blood Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Blood Cancer Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Blood Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Blood Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Blood Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Blood Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Blood Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Blood Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Blood Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Blood Cancer Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Blood Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Blood Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Blood Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Blood Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Blood Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Blood Cancer Therapeutics
Table 41. Key Market Challenges & Risks of Blood Cancer Therapeutics
Table 42. Key Industry Trends of Blood Cancer Therapeutics
Table 43. Global Blood Cancer Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Blood Cancer Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Blood Cancer Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Blood Cancer Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. AbbVie Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 48. AbbVie Blood Cancer Therapeutics Product Offered
Table 49. AbbVie Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. AbbVie Main Business
Table 51. AbbVie Latest Developments
Table 52. AstraZeneca Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 53. AstraZeneca Blood Cancer Therapeutics Product Offered
Table 54. AstraZeneca Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. Bristol-Myers Squibb Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 58. Bristol-Myers Squibb Blood Cancer Therapeutics Product Offered
Table 59. Bristol-Myers Squibb Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Bristol-Myers Squibb Main Business
Table 61. Bristol-Myers Squibb Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Blood Cancer Therapeutics Product Offered
Table 64. GlaxoSmithKline Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. GlaxoSmithKline Main Business
Table 66. GlaxoSmithKline Latest Developments
Table 67. Roche Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 68. Roche Blood Cancer Therapeutics Product Offered
Table 69. Roche Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Novartis Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 73. Novartis Blood Cancer Therapeutics Product Offered
Table 74. Novartis Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Boehringer Ingelheim Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 78. Boehringer Ingelheim Blood Cancer Therapeutics Product Offered
Table 79. Boehringer Ingelheim Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Pfizer Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 83. Pfizer Blood Cancer Therapeutics Product Offered
Table 84. Pfizer Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Sanofi Details, Company Type, Blood Cancer Therapeutics Area Served and Its Competitors
Table 88. Sanofi Blood Cancer Therapeutics Product Offered
Table 89. Sanofi Blood Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Blood Cancer Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Cancer Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Blood Cancer Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Blood Cancer Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Blood Cancer Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Blood Cancer Therapeutics Market Size Market Share by Type in 2024
Figure 10. Blood Cancer Therapeutics in Cancer Research Centers
Figure 11. Global Blood Cancer Therapeutics Market: Cancer Research Centers (2020-2025) & ($ millions)
Figure 12. Blood Cancer Therapeutics in Cancer Hospital
Figure 13. Global Blood Cancer Therapeutics Market: Cancer Hospital (2020-2025) & ($ millions)
Figure 14. Blood Cancer Therapeutics in Surgical Centers
Figure 15. Global Blood Cancer Therapeutics Market: Surgical Centers (2020-2025) & ($ millions)
Figure 16. Blood Cancer Therapeutics in Clinics
Figure 17. Global Blood Cancer Therapeutics Market: Clinics (2020-2025) & ($ millions)
Figure 18. Global Blood Cancer Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Blood Cancer Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Blood Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Blood Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Blood Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Blood Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Blood Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Blood Cancer Therapeutics Value Market Share by Country in 2024
Figure 26. United States Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Blood Cancer Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Blood Cancer Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Blood Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Blood Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Blood Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Blood Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Blood Cancer Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Blood Cancer Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Blood Cancer Therapeutics Market Size 2026-2031 ($ millions)